Clinical trial
Phase III Randomized,Multicenter Non-inferiority Study to Evaluate the Efficacy and Safety of Shorter Benznidazole Regimens Compared to the Standard Regimen to Treat Adult Patients With Chronic Chagas Disease
NCT04897516 is registered in ClinicalTrials.gov with Laboratorio Elea Phoenix S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Randomized,Multicenter Non-inferiority Study to Evaluate the Efficacy and Safety of Shorter Benznidazole Regimens Compared to the Standard Regimen to Treat Adult Patients With Chronic Chagas Disease
- Lead sponsor
- Laboratorio Elea Phoenix S.A.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 28, 2021
- Completion date
- December 1, 2026
- Enrollment
- 300 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.